Accessibility Statement Skip Navigation
  • Resources
  • Investor Relations
  • Journalists
  • Agencies
  • Client Login
  • Send a Release
Return to PR Newswire homepage
  • News
  • Products
  • Contact
Search
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News Releases view all

    • News in Focus
        • Browse News Releases

        • All News Releases
        • All Public Company
        • English-only
        • News Releases Overview

        • Multimedia Gallery

        • All Multimedia
        • All Photos
        • All Videos
        • Multimedia Gallery Overview

        • Trending Topics

        • All Trending Topics
    • Business & Money
        • Auto & Transportation

        • Aerospace, Defense
        • Air Freight
        • Airlines & Aviation
        • Automotive
        • Maritime & Shipbuilding
        • Railroads and Intermodal Transportation
        • Supply Chain/Logistics
        • Transportation, Trucking & Railroad
        • Travel
        • Trucking and Road Transportation
        • Auto & Transportation Overview

        • View All Auto & Transportation

        • Business Technology

        • Blockchain
        • Broadcast Tech
        • Computer & Electronics
        • Computer Hardware
        • Computer Software
        • Data Analytics
        • Electronic Commerce
        • Electronic Components
        • Electronic Design Automation
        • Financial Technology
        • High Tech Security
        • Internet Technology
        • Nanotechnology
        • Networks
        • Peripherals
        • Semiconductors
        • Business Technology Overview

        • View All Business Technology

        • Entertain­ment & Media

        • Advertising
        • Art
        • Books
        • Entertainment
        • Film and Motion Picture
        • Magazines
        • Music
        • Publishing & Information Services
        • Radio & Podcast
        • Television
        • Entertainment & Media Overview

        • View All Entertain­ment & Media

        • Financial Services & Investing

        • Accounting News & Issues
        • Acquisitions, Mergers and Takeovers
        • Banking & Financial Services
        • Bankruptcy
        • Bond & Stock Ratings
        • Conference Call Announcements
        • Contracts
        • Cryptocurrency
        • Dividends
        • Earnings
        • Earnings Forecasts & Projections
        • Financing Agreements
        • Insurance
        • Investments Opinions
        • Joint Ventures
        • Mutual Funds
        • Private Placement
        • Real Estate
        • Restructuring & Recapitalization
        • Sales Reports
        • Shareholder Activism
        • Shareholder Meetings
        • Stock Offering
        • Stock Split
        • Venture Capital
        • Financial Services & Investing Overview

        • View All Financial Services & Investing

        • General Business

        • Awards
        • Commercial Real Estate
        • Corporate Expansion
        • Earnings
        • Environmental, Social and Governance (ESG)
        • Human Resource & Workforce Management
        • Licensing
        • New Products & Services
        • Obituaries
        • Outsourcing Businesses
        • Overseas Real Estate (non-US)
        • Personnel Announcements
        • Real Estate Transactions
        • Residential Real Estate
        • Small Business Services
        • Socially Responsible Investing
        • Surveys, Polls and Research
        • Trade Show News
        • General Business Overview

        • View All General Business

    • Science & Tech
        • Consumer Technology

        • Artificial Intelligence
        • Blockchain
        • Cloud Computing/Internet of Things
        • Computer Electronics
        • Computer Hardware
        • Computer Software
        • Consumer Electronics
        • Cryptocurrency
        • Data Analytics
        • Electronic Commerce
        • Electronic Gaming
        • Financial Technology
        • Mobile Entertainment
        • Multimedia & Internet
        • Peripherals
        • Social Media
        • STEM (Science, Tech, Engineering, Math)
        • Supply Chain/Logistics
        • Wireless Communications
        • Consumer Technology Overview

        • View All Consumer Technology

        • Energy & Natural Resources

        • Alternative Energies
        • Chemical
        • Electrical Utilities
        • Gas
        • General Manufacturing
        • Mining
        • Mining & Metals
        • Oil & Energy
        • Oil and Gas Discoveries
        • Utilities
        • Water Utilities
        • Energy & Natural Resources Overview

        • View All Energy & Natural Resources

        • Environ­ment

        • Conservation & Recycling
        • Environmental Issues
        • Environmental Policy
        • Environmental Products & Services
        • Green Technology
        • Natural Disasters
        • Environment Overview

        • View All Environ­ment

        • Heavy Industry & Manufacturing

        • Aerospace & Defense
        • Agriculture
        • Chemical
        • Construction & Building
        • General Manufacturing
        • HVAC (Heating, Ventilation and Air-Conditioning)
        • Machinery
        • Machine Tools, Metalworking and Metallurgy
        • Mining
        • Mining & Metals
        • Paper, Forest Products & Containers
        • Precious Metals
        • Textiles
        • Tobacco
        • Heavy Industry & Manufacturing Overview

        • View All Heavy Industry & Manufacturing

        • Telecomm­unications

        • Carriers and Services
        • Mobile Entertainment
        • Networks
        • Peripherals
        • Telecommunications Equipment
        • Telecommunications Industry
        • VoIP (Voice over Internet Protocol)
        • Wireless Communications
        • Telecommunications Overview

        • View All Telecomm­unications

    • Lifestyle & Health
        • Consumer Products & Retail

        • Animals & Pets
        • Beers, Wines and Spirits
        • Beverages
        • Bridal Services
        • Cannabis
        • Cosmetics and Personal Care
        • Fashion
        • Food & Beverages
        • Furniture and Furnishings
        • Home Improvement
        • Household, Consumer & Cosmetics
        • Household Products
        • Jewelry
        • Non-Alcoholic Beverages
        • Office Products
        • Organic Food
        • Product Recalls
        • Restaurants
        • Retail
        • Supermarkets
        • Toys
        • Consumer Products & Retail Overview

        • View All Consumer Products & Retail

        • Entertain­ment & Media

        • Advertising
        • Art
        • Books
        • Entertainment
        • Film and Motion Picture
        • Magazines
        • Music
        • Publishing & Information Services
        • Radio & Podcast
        • Television
        • Entertainment & Media Overview

        • View All Entertain­ment & Media

        • Health

        • Biometrics
        • Biotechnology
        • Clinical Trials & Medical Discoveries
        • Dentistry
        • FDA Approval
        • Fitness/Wellness
        • Health Care & Hospitals
        • Health Insurance
        • Infection Control
        • International Medical Approval
        • Medical Equipment
        • Medical Pharmaceuticals
        • Mental Health
        • Pharmaceuticals
        • Supplementary Medicine
        • Health Overview

        • View All Health

        • Sports

        • General Sports
        • Outdoors, Camping & Hiking
        • Sporting Events
        • Sports Equipment & Accessories
        • Sports Overview

        • View All Sports

        • Travel

        • Amusement Parks and Tourist Attractions
        • Gambling & Casinos
        • Hotels and Resorts
        • Leisure & Tourism
        • Outdoors, Camping & Hiking
        • Passenger Aviation
        • Travel Industry
        • Travel Overview

        • View All Travel

    • Policy & Public Interest
        • Policy & Public Interest

        • Advocacy Group Opinion
        • Animal Welfare
        • Congressional & Presidential Campaigns
        • Corporate Social Responsibility
        • Domestic Policy
        • Economic News, Trends, Analysis
        • Education
        • Environmental
        • European Government
        • FDA Approval
        • Federal and State Legislation
        • Federal Executive Branch & Agency
        • Foreign Policy & International Affairs
        • Homeland Security
        • Labor & Union
        • Legal Issues
        • Natural Disasters
        • Not For Profit
        • Patent Law
        • Public Safety
        • Trade Policy
        • U.S. State Policy
        • Policy & Public Interest Overview

        • View All Policy & Public Interest

    • People & Culture
        • People & Culture

        • Aboriginal, First Nations & Native American
        • African American
        • Asian American
        • Children
        • Diversity, Equity & Inclusion
        • Hispanic
        • Lesbian, Gay & Bisexual
        • Men's Interest
        • People with Disabilities
        • Religion
        • Senior Citizens
        • Veterans
        • Women
        • People & Culture Overview

        • View All People & Culture

    • Explore Our Platform
    • Plan Campaigns
    • Create with AI
    • Distribute Press Releases
    • Report Results
    • Amplify Content
    • All Products
    • General Inquiries
    • Editorial Bureaus
    • Partnerships
    • Media Inquiries
    • Worldwide Offices
    • Hamburger menu
    • PR Newswire: news distribution, targeting and monitoring
    • Send a Release
      • ALL CONTACT INFO
      • Contact Us

        888-776-0942
        from 8 AM - 10 PM ET

    • Searching for your content...

      No results found. Please change your search terms and try again.

      News Releases

      view all
      Close menu
    • News
    • Products
    • Contact
      • Send a Release
      • Client Login
      • Resources
      • Blog
      • Journalists
      • RSS
      • 3 News in Focus
      • 5 Business & Money
      • 5 Science & Tech
      • 5 Lifestyle & Health
      • 1 Policy & Public Interest
      • 1 People & Culture
      • Send a Release
      • Client Login
      • Resources
      • Blog
      • Journalists
      • RSS
      • Explore Our Platform
      • Plan Campaigns
      • Create with AI
      • Distribute Press Releases
      • Report Results
      • Amplify Content
      • All Products
      • Send a Release
      • Client Login
      • Resources
      • Blog
      • Journalists
      • RSS
      • General Inquiries
      • Editorial Bureaus
      • Partnerships
      • Media Inquiries
      • Worldwide Offices
      • Send a Release
      • Client Login
      • Resources
      • Blog
      • Journalists
      • RSS
      Close submenu (News in Focus) News in Focus
      • Browse News Releases
      • Multimedia Gallery
      • Trending Topics
      Close submenu (Business & Money) Business & Money
      • Auto & Transportation
      • Business Technology
      • Entertain­ment & Media
      • Financial Services & Investing
      • General Business
      Close submenu (Science & Tech) Science & Tech
      • Consumer Technology
      • Energy & Natural Resources
      • Environ­ment
      • Heavy Industry & Manufacturing
      • Telecomm­unications
      Close submenu (Lifestyle & Health) Lifestyle & Health
      • Consumer Products & Retail
      • Entertain­ment & Media
      • Health
      • Sports
      • Travel
      Close submenu (Policy & Public Interest) Policy & Public Interest
      • Policy & Public Interest
      Close submenu (People & Culture) People & Culture
      • People & Culture

      Fapon Connects Enzyme Innovation with Real-World Applications at AMP 2026

      Fapon

      News provided by

      Fapon

      Nov 18, 2026, 08:50 ET

      Share this article

      Share this article


      Fapon-hosted workshop highlights AI-powered enzyme engineering and application insights from full-length transcriptomics

      SEATTLE, Nov. 18, 2026 /PRNewswire/ -- Fapon, a globally leading life sciences organization, has concluded its participation in the Association for Molecular Pathology (AMP) 2026 Annual Meeting & Expo, held November 10–14 at the Seattle Convention Center. At Booth 1905, Fapon presented its latest advances in AI-engineered enzymes, application-specific reverse transcription solutions, and integrated RNA and DNA library preparation workflows, connecting innovations in enzyme development with the evolving needs of molecular diagnostics.

      A key highlight of Fapon's participation was its corporate workshop, "Unlocking the Full Potential of Enzymes in Molecular Diagnostics," held on November 11. The session brought together perspectives on enzyme engineering and real-world applications, illustrating how advances in enzyme design can support performance across qPCR, RT-qPCR, NGS, and isothermal amplification.

      Fapon's Ning Wu, Ph.D., presented the company's enzyme engineering platform, which combines AI-driven design with high-throughput wet-lab screening in an iterative process. Experimental results are fed back into the model to guide the selection of candidates for subsequent design rounds. After two rounds of design and selection, AI-engineered MMLV reverse transcriptases can generate cDNA from RNA templates up to 9 kb in length at 60°C. The session also discussed TeloScript II, a next-generation reverse transcriptase designed to extend full-length cDNA synthesis in long-read sequencing workflows, even for templates with complex secondary structures. An invited guest speaker shared application insights from a full-length transcriptomics study, demonstrating how long-read sequencing can help resolve complex fusion genes and transcript isoforms. The discussion also highlighted the role of reverse transcription performance in supporting demanding RNA sequencing workflows.

      Advancing Enzyme Performance Across Molecular Diagnostic Workflows

      Throughout the exhibition, Fapon showcased its enzyme portfolio developed through AI-driven design and experimental validation. Featured solutions included ProPrime II Taq DNA Polymerase, a second-generation antibody-based hot-start polymerase that is ultrafast and highly inhibitor-resistant. Its special antibody formulation enables complete antibody release within 10 seconds of heat activation. It enables 41 cycles of quadruplex qPCR to be completed in under 20 minutes. The enzyme has also been evaluated for direct amplification in 5% whole blood and in the presence of nine common PCR inhibitors. It is designed for multiplexed qPCR panels and near-patient testing, where speed and tolerance to challenging sample matrices are important for assay performance.

      Another featured solution was MeloScript III WS Reverse Transcriptase, a third-generation warm-start RT specifically designed for one-step RT-qPCR. Like ProPrime II, it is highly inhibitor-resistant, and it maintains reverse transcription performance after 10 minutes at 52–64°C, supporting fast and specific one-step RT-qPCR. Its glycerol-free, lyophilization-ready format makes it suitable for lyophilized reagents and near-patient assay formats.

      In addition to MeloScript III WS for RT-qPCR, Fapon also highlighted other application-specific reverse transcription solutions, including PreciAmp HS RT for RT-LAMP applications and VeloScript I for long-read sequencing and NGS workflows. PreciAmp HS RT maintains performance in the presence of inhibitors such as ethanol, viral preservation solutions, and sample release agents. VeloScript I synthesizes full-length cDNA up to 15 kb, even in the presence of complex secondary RNA structures, using RNA inputs ranging from 10 pg to 10 μg. Together with its RNA library preparation solutions, the portfolio supports a range of RNA applications, from reverse transcription to downstream sequencing.

      Additional solutions on display included the NK081 Poly(A) mRNA Magnetic Isolation Module, which removes 95% or more of rRNA in under 40 minutes, and the NextGen Universal FS DNA Library Prep Kit, which completes library preparation in under one hour. These solutions broaden Fapon's offerings across RNA and DNA sample preparation.

      Connecting with the Molecular Diagnostics Community

      During AMP 2026, Fapon's team connected with molecular pathology researchers, assay developers, and IVD manufacturers to exchange perspectives on emerging application needs and technical challenges. These discussions provided opportunities to explore Fapon's enzyme technologies, integrated workflow solutions, and potential areas for collaboration.

      Fapon thanks everyone who visited its booth and participated in the workshop. The company looks forward to continuing conversations with the molecular diagnostics community and supporting partners with innovative enzyme technologies and workflow solutions.

      To learn more about Fapon's molecular diagnostics solutions, request product information or evaluation samples, or discuss potential collaboration opportunities, please contact:

      Email: [email protected]

      Website: https://us.faponbiotech.com/

      About Fapon

      Fapon, a globally leading life sciences organization, is redefining the R&D paradigm in diagnostics and therapeutics through a cutting-edge "AI-driven + a closed loop of dry and wet experiments" model. This approach significantly accelerates novel biomarker/target discovery and translation. We have established an integrated business structure that combines AI-powered innovative discovery, one-stop diagnostic solutions and novel therapies. Our products and services have covered the full spectrum of health management across the entire lifecycle, and accelerated the development of precision medicine. We have built a global network for R&D, manufacturing, marketing, sales and services, with products reaching over 70 countries and regions and more than 2,500 partners worldwide. Leveraging our AI-driven, diagnostics and therapeutics closed-loop innovation platforms, we connect healthcare resources across the globe, continuously contributing to a healthier and better future for all.

      Follow us on LinkedIn (Fapon) or visit https://us.faponbiotech.com/

      SOURCE Fapon

      Modal title

      Also from this source

      Fapon präsentiert auf der MEDICA 2026 Lösungen für die lokale Fertigung und rekombinante Qualitätskontrollmaterialien

      Fapon präsentiert auf der MEDICA 2026 Lösungen für die lokale Fertigung und rekombinante Qualitätskontrollmaterialien

      Fapon, ein weltweit führendes Unternehmen im Bereich der Biowissenschaften, wird vom 16. bis 19. November auf der MEDICA 2026 in Düsseldorf...

      Fapon mettra en avant les solutions de production locale et les matériaux de contrôle qualité (CQ) recombinants lors du salon MEDICA 2026

      Fapon mettra en avant les solutions de production locale et les matériaux de contrôle qualité (CQ) recombinants lors du salon MEDICA 2026

      Fapon, une organisation mondiale leader dans le domaine des sciences de la vie, sera présent au salon MEDICA 2026 du 16 au 19 novembre à Düsseldorf,...

      More Releases From This Source

      Explore

      Biotechnology

      Biotechnology

      Medical Pharmaceuticals

      Medical Pharmaceuticals

      Pharmaceuticals

      Pharmaceuticals

      Health Care & Hospitals

      Health Care & Hospitals

      News Releases in Similar Topics

      Contact PR Newswire

      • Call PR Newswire at 888-776-0942
        from 8 AM - 9 PM ET
      • Chat with an Expert
      • General Inquiries
      • Editorial Bureaus
      • Partnerships
      • Media Inquiries
      • Worldwide Offices

      Products

      • Explore Our Platform
      • Plan Campaigns
      • Create with AI
      • Distribute Press Releases
      • Report Results
      • Amplify Content

      About

      • About PR Newswire
      • About Cision
      • Careers
      • Accessibility Statement
      • APAC
      • APAC - Simplified Chinese
      • APAC - Traditional Chinese
      • Brazil
      • Canada
      • Czech
      • Denmark
      • Finland
      • France
      • Germany
      • India
      • Indonesia
      • Israel
      • Italy
      • Japan
      • Korea
      • Mexico
      • Middle East
      • Middle East - Arabic
      • Netherlands
      • Norway
      • Poland
      • Portugal
      • Russia
      • Slovakia
      • Spain
      • Sweden
      • United Kingdom
      • Vietnam

      My Services

      • All New Releases
      • Platform Login
      • Data Privacy

      Do not sell or share my personal information:

      • Submit via [email protected] 
      • Call Privacy toll-free: 877-297-8921

      Contact PR Newswire

      Products

      About

      My Services
      • All News Releases
      • Platform Login
      • ProfNet
      Call PR Newswire at
      888-776-0942
      • Terms of Use
      • Privacy Policy
      • Information Security Policy
      • Site Map
      • RSS
      • Cookies
      Copyright © 2026 Cision US Inc.